PURPOSE: Acute liver failure (ALF) is characterized by a rapid and massive destruction of hepatocytes. The role of oxidative stress in perpetuating the injury is undefined and may be a potential therapeutic target. Our aim was to study serial variation in oxidative stress and antioxidant status in patients with ALF. METHODS: The study involved a prospective case-control study set in a tertiary care referral center. Thirty-two consecutive patients admitted with ALF were included with 23 healthy controls for comparison. Level of systemic oxidative stress as defined by superoxide dismutase (SOD), lipid peroxidation products (thiobarbituric acid reactive derivatives [TBARS]), and the total antioxidant capacity as the ferric reducing ability of plasma (FRAP) was measured at baseline on days 3 and 7. RESULTS: The patients were aged 24 years (range 13-60 years) and included 20 females. Thirteen (40.6%) patients died. Patients with ALF had significantly increased systemic oxidative stress at presentation, as reflected by higher levels of SOD (P < 0.001) and TBARS (P < 0.001) than controls. Both TBARS levels and FRAP decreased progressively from admission to the end of first week among the survivors (P = 0.004 and 0.015, respectively). The antioxidant status reflected by FRAP (P = 0.001) was significantly lower in ALF patients than controls. No relation was found between the level of oxidative stress and the mortality or complications. CONCLUSION: A high level of systemic oxidative stress exists in ALF, with depletion of antioxidant reserves. Further studies are needed to define the clinical correlation of the large pro-oxidant burden.
PURPOSE:Acute liver failure (ALF) is characterized by a rapid and massive destruction of hepatocytes. The role of oxidative stress in perpetuating the injury is undefined and may be a potential therapeutic target. Our aim was to study serial variation in oxidative stress and antioxidant status in patients with ALF. METHODS: The study involved a prospective case-control study set in a tertiary care referral center. Thirty-two consecutive patients admitted with ALF were included with 23 healthy controls for comparison. Level of systemic oxidative stress as defined by superoxide dismutase (SOD), lipid peroxidation products (thiobarbituric acid reactive derivatives [TBARS]), and the total antioxidant capacity as the ferric reducing ability of plasma (FRAP) was measured at baseline on days 3 and 7. RESULTS: The patients were aged 24 years (range 13-60 years) and included 20 females. Thirteen (40.6%) patients died. Patients with ALF had significantly increased systemic oxidative stress at presentation, as reflected by higher levels of SOD (P < 0.001) and TBARS (P < 0.001) than controls. Both TBARS levels and FRAP decreased progressively from admission to the end of first week among the survivors (P = 0.004 and 0.015, respectively). The antioxidant status reflected by FRAP (P = 0.001) was significantly lower in ALFpatients than controls. No relation was found between the level of oxidative stress and the mortality or complications. CONCLUSION: A high level of systemic oxidative stress exists in ALF, with depletion of antioxidant reserves. Further studies are needed to define the clinical correlation of the large pro-oxidant burden.
Authors: E Broide; E Klinowski; G Koukoulis; N Hadzic; B Portmann; A Baker; E Scapa; G Mieli-Vergani Journal: J Hepatol Date: 2000-02 Impact factor: 25.083
Authors: Raj Vuppalanchi; Ravi Juluri; Lauren N Bell; Marwan Ghabril; Lisa Kamendulis; James E Klaunig; Romil Saxena; David Agarwal; Matthew S Johnson; Naga Chalasani Journal: Am J Med Sci Date: 2011-10 Impact factor: 2.378
Authors: Zeng Fan; Chen EnQiang; Du Ling Yao; Yan LiBo; Li Hong; Bai Lang; Feng Ping; Tang Hong Journal: PLoS One Date: 2017-04-20 Impact factor: 3.240